We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

15 Jun 2011 07:00

RNS Number : 4473I
Sopheon PLC
15 June 2011
 



SOPHEON PLC

 

AGM Statement

 

At the Annual General Meeting of Sopheon plc to be held later today, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

 

"In our Full Year results, we were delighted to report strong growth with revenues up by 28% to £10.5m, and a turnaround in profits, from an EBITDA loss of £0.2m to a profit of £1.5m. After a difficult 2009, which included taking some very tough spending adjustments, it was gratifying to see a return to growth and such a strong improvement in our bottom-line performance. We also strengthened the Group's working capital position by refreshing our debt facilities with BlueCrest Capital, and by extending the maturity of convertible debt. This allowed us to enter 2011 with the confidence to expand headcount in targeted areas of the business. Most recently, we announced that we had filled two key leadership positions by hiring two vice presidents responsible for the EMEA region and for product development respectively.

 

In our trading update on 5 May, we noted that we had concluded 11 new and extension license orders since the start of the year; we are pleased to report this has since been increased to 15. Full year revenue visibility for 2011 from contracted business and recurring revenue streams has now risen to £6.6 million compared to £6.1 million on 5 May. This also compares favorably to the £6.0 million visibility noted at the time of our AGM statement a year ago. Nevertheless, last year this was followed by a very strong close to the second quarter, leading to record first half revenues. As at the time of last year's AGM announcement, we currently have a very substantial amount of business that we are working to close in the remaining weeks of June. If successful, this would enable us to exceed the strong first half revenue performance of last year. In this regard, customer procurement practices remain thorough and cautious which, as we have noted in previous announcements, can make it difficult to accurately predict the timing and value of individual sales.

 

In our Statement of 5 May we noted that market interest in Sopheon's solutions was showing a strong positive trend. That trend continues. Nearly twice as many prospective buyers visited our website and responded to our promotional campaigns from the start of this year through early June compared to the same period in 2010. This surge is partly attributable to prominent affirmation of the value of our software by influential third-party sources, including analysts and industry publications. One of our principal advantages in garnering such attention is that Sopheon is unique in offering a software system that provides end-to-end support encompassing product strategy, ideation and product development process execution. We are energized by the strength of our market position, and by our potential for continued, substantial growth." 

 

For further information contact:

Barry Mence, Chairman

Sopheon plc

Tel : + 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

Tel : + 44 (0) 1483 685 735

Charles Cunningham/ Charlotte Stranner/ Joanna Weaving

finnCap

Tel: +44 (0) 20 7600 1658

Nicholas Nelson / Guy McDougall

Hansard Communications

Tel : + 44 (0) 20 7245 1100

Claire Verhagen

Citigate First Financial

Tel : + 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) is an international provider of software and services that help organisations improve the business impact of product innovation. Sopheon's solutions automate and govern the innovation process, enabling companies to increase revenue and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BAE Systems, BASF, Corning, Electrolux, Honeywell, Novartis and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com. 

 

Revenue visibility is defined in Note4 of Sopheon's 2010 annual report which is available from the investor section of www.sopheon.com .

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLFFEIRAISLIL
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.